PRESS-RELEASE ·Filed Mar 18, 2026
Press release · Earnings
Actionable Insight • Neutral
Traders should prepare for potential volatility following the March 25 earnings release; until then, no fundamental financial assessment can be made.
Final — all horizons settled through T+60d
ICU ▲ +37.89% at T+60d
NEUTRAL call +37.89% · α vs SPY +23.54% · entry $2.27 → $3.13
T+1d
-1.76%
call -1.76% · α -0.02%
$2.23
settled 7mo ago
T+5d
+22.91%
call +22.91% · α +25.12%
$2.79
settled 7mo ago
T+20d
+85.02%
call +85.02% · α +77.40%
$4.20
settled 7mo ago
T+60d
+37.89%
call +37.89% · α +23.54%
$3.13
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
SeaStar Medical announced it will report its Q4 and full-year 2025 financial results on March 25, 2026, followed by a webcast and conference call. The press release provides no actual financial data, only logistical details for the upcoming earnings announcement.
Key Facts
- SeaStar Medical will report Q4 and year-end 2025 financial results on March 25, 2026, after market close.
- Company will host a webcast and conference call at 4:30 p.m. ET to discuss results.
- No financial figures (revenue, EPS, guidance) were disclosed in this release.
- QUELIMMUNE (SCD-PED) is the company's first FDA-approved product for pediatric AKI due to sepsis.
- Company is conducting the NEUTRALIZE-AKI pivotal trial for adult AKI patients.
Financial Impact
No financial data disclosed
Risk Factors
- Lack of disclosed financials limits ability to assess performance or trajectory ahead of the report.
- Low market cap ($9M) increases susceptibility to volatility post-earnings.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3258589 |
4 reports for ICU
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 22d ago | 8-K | $3.19 $3.59 | ▼ −12.54% | ▼ −12.68% | $2.52 (+21.00%) |
May 6, 2026 24w ago | Press Release | $4.87 $4.84 | ▼ −0.62% | ▼ −1.75% | $2.52 (−48.25%) |
Mar 25, 2026 30w ago | Press Release | $2.79 $4.31 | ▲ +54.48% | ▲ +52.85% | $2.52 (−9.68%) |
Mar 18, 2026 31w ago | Press Release | $2.27 $2.79 | ▲ +22.91% | ▲ +25.12% | $2.52 (+11.01%) |
Showing 4 of 4
US Market Status
Market Closed — Opens in 8h 21m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers